BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2969684)

  • 1. Abnormal scleral findings in uveal effusion syndrome.
    Ward RC; Gragoudas ES; Pon DM; Albert DM
    Am J Ophthalmol; 1988 Aug; 106(2):139-46. PubMed ID: 2969684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histological observations on the sclera in uveal effusion].
    Tagami N; Uyama M; Yamada K; Kosaki J; Ohkuma H; Tomoda T
    Nippon Ganka Gakkai Zasshi; 1993 Feb; 97(2):268-74. PubMed ID: 8475840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathologic studies on idiopathic uveal effusion.
    Weng N; Hu W; Sun X; Li L; Fu S
    Zhonghua Yan Ke Za Zhi; 1995 Nov; 31(6):403-11. PubMed ID: 8762565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uveal effusion syndrome and trans-scleral flow.
    Forrester JV; Lee WR; Kerr PR; Dua HS
    Eye (Lond); 1990; 4 ( Pt 2)():354-65. PubMed ID: 2379646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology.
    Uyama M; Takahashi K; Kozaki J; Tagami N; Takada Y; Ohkuma H; Matsunaga H; Kimoto T; Nishimura T
    Ophthalmology; 2000 Mar; 107(3):441-9. PubMed ID: 10711879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of scleral thickness in uveal effusion syndrome.
    Lam A; Sambursky RP; Maguire JI
    Am J Ophthalmol; 2005 Aug; 140(2):329-31. PubMed ID: 16086964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleral punch method with topical mitomycin C for safe revision of failed deep sclerectomy in nanophthalmic uveal effusion syndrome.
    Sabrosa NA; Smith HB; MacLaren RE
    Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):999-1001. PubMed ID: 19130073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.
    Jackson TL; Hussain A; Morley AM; Sullivan PM; Hodgetts A; El-Osta A; Hillenkamp J; Charles SJ; Sheard R; Williamson TH; Kumar A; Laidlaw DA; Woon WH; Costen MJ; Luff AJ; Marshall J
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5033-40. PubMed ID: 18552396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of nanophthalmic uveal effusion.
    Morita H; Funata M; Kusakari T; Yoshino Y; Kiyosawa M
    Ophthalmologica; 1993; 207(1):30-6. PubMed ID: 8278171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotomy in uveal effusion syndrome.
    Faulborn J; Kölli H
    Retina; 1999; 19(6):504-7. PubMed ID: 10606449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to the surgical management of idiopathic uveal effusion syndrome.
    Schneiderman TE; Johnson MW
    Am J Ophthalmol; 1997 Feb; 123(2):262-3. PubMed ID: 9186138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report.
    Kaewsangthong K; Thoongsuwan S; Uiprasertkul M; Phasukkijwatana N
    BMC Ophthalmol; 2020 Jul; 20(1):311. PubMed ID: 32727414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-thickness sclerotomy for uveal effusion syndrome.
    Kong M; Kim JH; Kim SJ; Kang SW
    Korean J Ophthalmol; 2013 Aug; 27(4):294-8. PubMed ID: 23908578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uveal effusion syndrome. A new hypothesis concerning pathogenesis and technique of surgical treatment.
    Gass JD
    Retina; 1983; 3(3):159-63. PubMed ID: 6635350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal effusion syndrome: a new hypothesis concerning pathogenesis and technique of surgical treatment.
    Gass JD
    Trans Am Ophthalmol Soc; 1983; 81():246-60. PubMed ID: 6676971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleral window surgery and topical mitomycin C for nanophthalmic uveal effusion complicated by renal failure: case report.
    Suzuki Y; Nishina S; Azuma N
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):755-7. PubMed ID: 17024441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
    Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
    Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USE OF FIBEROPTIC-GUIDED CO2 LASER IN THE TREATMENT OF UVEAL EFFUSION.
    Bausili MM; Raja H; Kotowski J; Nadal J; Salomao DR; Keenum D; Pulido JS
    Retin Cases Brief Rep; 2017 Summer; 11(3):191-194. PubMed ID: 27768636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C.
    Akduman L; Adelberg DA; Del Priore LV
    Ophthalmic Surg Lasers; 1997 Apr; 28(4):325-7. PubMed ID: 9101574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified ultrasound-guided surgical technique for the management of the uveal effusion syndrome in patients with normal axial length and scleral thickness.
    Ghazi NG; Richards CP; Abazari A
    Retina; 2013 Jun; 33(6):1211-9. PubMed ID: 23503341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.